Medical Societies Endorse Evidence-Based Respiratory Vaccine Guidance

Medical Societies Endorse Evidence-Based Respiratory Vaccine Guidance

Multi-Society Panel Rejects 2025 Vaccine Schedule Updates A coalition of four major medical societies has formally endorsed a set of influenza, RSV, and COVID-19 vaccine recommendations, citing concerns over changes to the federal immunization schedule. The panel’s decision follows a series of updates to the Centers for Disease Control and Prevention (CDC) and Advisory Committee … Read more

India study finds melioidosis in 262 patients

India study finds melioidosis in 262 patients

Between January 2023 and December 2025, a multicentre study led by Nitin Gupta at the Kasturba Medical College, Manipal Academy of Higher Education, tracked 2,953 high-risk hospitalised adults across 15 Indian tertiary-care centres and found culture-confirmed melioidosis in 262 patients, according to The Lancet Global Health, The Hindu reported. Burkholderia pseudomallei Infections Emerge Across Indian … Read more

Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women

Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women

Women Achieve 15.5% Weight Loss in Remote GLP-1RA Care Program A new real-world study published in Nature reveals that women receiving GLP-1 receptor agonist therapy through a digitally delivered care model lost an average of 15.5% of their body weight at six months. The evaluation tracked a large cohort of female patients outside conventional healthcare … Read more

AI Accelerates Rabies Detection in Cell Cultures

AI Accelerates Rabies Detection in Cell Cultures

Researchers at the University of Surrey’s Institute for People-Centred AI and the Animal and Plant Health Agency have developed a world-first artificial intelligence workflow to detect rabies in cell cultures and measure antibody concentrations. Rabies kills approximately 59,000 people annually despite being almost entirely preventable through vaccination, according to findings published in Nature Scientific Reports. … Read more

Nasal Adjuvant Protects Mice Against Respiratory Viruses for Months

Nasal Adjuvant Protects Mice Against Respiratory Viruses for Months

Researchers at The University of Tokyo have developed a nanosized vaccine adjuvant called K3-SPG that provides temporary, broad protection against respiratory viruses like influenza A and SARS-CoV-2 in animal models. Published in Science Advances, the study investigates how stimulating innate immunity could bridge the vulnerable gap before pathogen-specific vaccines become available during a pandemic. Testing … Read more

New Antibiotic Combinations for Recurrent Bacterial Vaginosis

Researchers at Monash University and Bayside Health’s Melbourne Sexual Health Centre are clinical-trialling antibiotic combinations to treat persistent bacterial vaginosis, following a landmark 2025 discovery in the New England Journal of Medicine that treating male partners cuts infection recurrence by over 60 percent. Antibiotic Trials Target Persistent Bacterial Vaginosis After Partner Treatment Discoveries Medical researchers … Read more

New National Guidelines Aim to Improve Sepsis Care

New multisociety clinical guidelines released by the Infectious Diseases Society of America and seven other professional groups aim to standardize hospital workflows and improve survival rates for sepsis, a dangerous full-body infection that kills at least 350,000 Americans annually. According to Taison Bell, MD, MBA, interim chair of UVA Health’s Department of Medicine, the initiative … Read more

Asthma Antiviral Nasal Spray Secures Clinical Trial Funding

A new Phase Ib clinical trial will evaluate whether a once-weekly dry powder nasal spray called INNA-051 can prime innate immune defenses and prevent viral complications in adult asthma patients, according to developer ENA Respiratory. The trial is backed by AUD $2.98 million in funding awarded through Biointelect Venturer, utilizing support from the Australian Government’s … Read more

COVID-19 Alters Sleep Breathing Patterns

A history of COVID-19 does not disrupt the primary physiological mechanisms of obstructive sleep apnea, according to a study published in the Journal of Clinical Medicine. Researchers discovered that while upper-airway collapsibility and muscle compensation remain stable, individuals with a prior infection exhibit a significantly stronger breathing response after brief nighttime awakenings. Core Sleep Apnea … Read more

Mosquito Bite Vaccine: A New Breakthrough in Immunity

Researchers at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, have developed a new vaccination approach that uses antimalarial drug compounds to transform mosquito bites from a source of deadly infection into natural immune boosters, according to a study published in Science. Targeting the Late Liver Stage to Build Durable Immunity The preclinical … Read more